These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28128669)

  • 1. Economic burden of comorbid chronic kidney disease and diabetes.
    McQueen RB; Farahbakhshian S; Bell KF; Nair KV; Saseen JJ
    J Med Econ; 2017 Jun; 20(6):585-591. PubMed ID: 28128669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes.
    Lage MJ; Boye KS; Bae JP; Wu J; Mody R; Botros FT
    J Med Econ; 2019 May; 22(5):447-454. PubMed ID: 30736708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 4. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 5. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease in Russia: the Ural eye and medical study.
    Bikbov MM; Zainullin RM; Kazakbaeva GM; Gilmanshin TR; Rakhimova EM; Rusakova IA; Bolshakova NI; Safiullina KR; Panda-Jonas S; Yakupova DF; Nikitin NA; Jonas JB
    BMC Nephrol; 2020 May; 21(1):198. PubMed ID: 32450794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients.
    Lascasas JMSS; Fonseca I; Malheiro J; Santos S; Campos A; Castro A; Moreira C; Correia S; Beirão I; Lobato L; Cabrita A
    J Bras Nefrol; 2019; 41(1):29-37. PubMed ID: 31063177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime incidence of CKD stages 3-5 in the United States.
    Grams ME; Chow EK; Segev DL; Coresh J
    Am J Kidney Dis; 2013 Aug; 62(2):245-52. PubMed ID: 23566637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
    Vupputuri S; Kimes TM; Calloway MO; Christian JB; Bruhn D; Martin AA; Nichols GA
    J Diabetes Complications; 2014; 28(1):10-6. PubMed ID: 24211091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.
    Malmgren L; McGuigan FE; Berglundh S; Westman K; Christensson A; Åkesson K
    Nephron; 2015; 130(4):245-55. PubMed ID: 26184510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synergistic effect of variability in estimated glomerular filtration rate with chronic kidney disease on all-cause mortality prediction in patients with type 2 diabetes: a retrospective cohort study.
    Chang YS; Li YH; Lee IT
    Cardiovasc Diabetol; 2021 Oct; 20(1):209. PubMed ID: 34663321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study.
    Baek SD; Baek CH; Kim JS; Kim SM; Kim JH; Kim SB
    Scand J Urol Nephrol; 2012 Jun; 46(3):232-8. PubMed ID: 22545920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression.
    Novak M; Mucsi I; Rhee CM; Streja E; Lu JL; Kalantar-Zadeh K; Molnar MZ; Kovesdy CP
    Diabetes Care; 2016 Nov; 39(11):1940-1947. PubMed ID: 27311494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.
    Benghanem Gharbi M; Elseviers M; Zamd M; Belghiti Alaoui A; Benahadi N; Trabelssi el H; Bayahia R; Ramdani B; De Broe ME
    Kidney Int; 2016 Jun; 89(6):1363-71. PubMed ID: 27165829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes associated with concordance of oral antidiabetic drug treatments to prescribing information in patients with type 2 diabetes mellitus and chronic kidney disease.
    Chen SY; Lee YC; Alas V; Greene M; Brixner D
    J Med Econ; 2013; 16(5):586-95. PubMed ID: 23402560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database.
    Wanner C; Schuchhardt J; Bauer C; Lindemann S; Brinker M; Kong SX; Kleinjung F; Horvat-Broecker A; Vaitsiakhovich T
    J Nephrol; 2023 Jan; 36(1):45-54. PubMed ID: 35567698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Cardiovascular Disease and Chronic Kidney Disease on Life Expectancy and Direct Medical Cost in a 10-Year Diabetes Cohort Study.
    Wan EYF; Chin WY; Yu EYT; Wong ICK; Chan EWY; Li SX; Cheung NKL; Wang Y; Lam CLK
    Diabetes Care; 2020 Aug; 43(8):1750-1758. PubMed ID: 32457057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.